Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 20, 2021
Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical TrialYun Xu, Yi Ren, Xindi Li, et al.Neuroimmunomodulation|December 14, 2018
Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6Yuzhen Wei, Haoxiao Chang, Xindi Li, et al.Analytica Chimica Acta|April 12, 2025
Blood detection of autoimmune encephalitis based on laser-induced breakdown spectroscopy and Raman spectroscopyZhifang Zhao, Wangshu Xu, Geer Teng, et al.Medicine|August 7, 2020
Anti-NMDA receptor encephalitis concomitant with myelin oligodendrocyte glycoprotein antibody diseases: A retrospective observational studyLi Du, Huabing Wang, Heng Zhou, et al.Multiple Sclerosis and Related Disorders|July 13, 2020
Intravenous immunoglobulin for acute attacks in neuromyelitis optica spectrum disorders (NMOSD)Xindi Li, De-Cai Tian, Moli Fan, et al.Computers in Biology and Medicine|May 15, 2024
Improving the classification of multiple sclerosis and cerebral small vessel disease with interpretable transfer attention neural networkWangshu Xu, Zhiwei Rong, Wenping Ma, et al.Frontiers in Immunology|October 4, 2024
CCL4 as a potential serum factor in differential diagnosis of central nervous system inflammatory diseases and gliomasTian-Jie Lyu, Jia Wang, Fengmao Zhao, et al.Frontiers in Immunology|January 13, 2023
Soluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNSTianshu Guo, Jia Ma, Jiali Sun, et al.Frontiers in Immunology|April 14, 2023
Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disordersYupeng Wang, Jiangping Bian, Mengyuan Yao, et al.Journal of Neuroimmunology|January 14, 2024
Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorderChengyi Zhang, Rui Liu, Bin Gao, et al.Pageof 3